LTFS
ARNA

Ladenburg Thalmann Financial Services’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$40K Sell
857
-57
-6% -$2.69K ﹤0.01% 3682
2019
Q3 		$43K Buy
914
+27
+3% +$1.52K ﹤0.01% 3555
2019
Q2 		$52K Buy
887
+193
+28% +$9.97K ﹤0.01% 3440
2019
Q1 		$31K Sell
694
-27
-4% -$1.24K ﹤0.01% 3740
2018
Q4 		$29K Sell
721
-158
-18% -$6.2K ﹤0.01% 3658
2018
Q3 		$40K Sell
879
-20
-2% -$811 ﹤0.01% 3481
2018
Q2 		$36K Hold
899
– – ﹤0.01% 3489
2018
Q1 		$36K Buy
899
+280
+45% +$10.9K ﹤0.01% 3489
2017
Q4 		$21K Hold
619
– – ﹤0.01% 3784
2017
Q3 		$16K Buy
619
+100
+19% +$2.29K ﹤0.01% 3823
2017
Q2 		$9K Sell
519
-1
-0.2% -$14 ﹤0.01% 4103
2017
Q1 		$7K Buy
520
+30
+6% +$444 ﹤0.01% 4190
2016
Q4 		$7K Hold
490
– – ﹤0.01% 4094
2016
Q3 		$8K Buy
490
+50
+11% +$829 ﹤0.01% 3964
2016
Q2 		$7K Hold
440
– – ﹤0.01% 3991
2016
Q1 		$8K Buy
440
+50
+13% +$801 ﹤0.01% 3854
2015
Q4 		$7K Sell
390
-40
-9% -$816 ﹤0.01% 3909
2015
Q3 		$8K Hold
430
– – ﹤0.01% 3696
2015
Q2 		$20K Sell
430
-90
-17% -$3.9K ﹤0.01% 3245
2015
Q1 		$23K Sell
520
-10
-2% -$465 ﹤0.01% 3103
2014
Q4 		$18K Sell
530
-50
-9% -$2.03K ﹤0.01% 3068
2014
Q3 		$24K Sell
580
-100
-15% -$4.46K ﹤0.01% 2522
2014
Q2 		$40K Hold
680
– – ﹤0.01% 2193
2014
Q1 		$43K Sell
680
-1,850
-73% -$123K ﹤0.01% 2077
2013
Q4 		$148K Buy
2,530
+755
+43% +$39.5K ﹤0.01% 1233
2013
Q3 		$94K Sell
1,775
-110
-6% -$7.39K ﹤0.01% 1436
2013
Q2 		$145K Buy
+1,885
New +$154K 0.01% 1127

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ARNA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Arena Pharmaceuticals Inc (ARNA) stake by 6.2% in Q4 2019, selling an estimated $2.69K and leaving 857 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3682.

Ladenburg Thalmann Financial Services first reported a position in ARNA in Q2 2013 and has held it in 27 quarters since. The position peaked at $148K in Q4 2013. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 857 shares of Arena Pharmaceuticals Inc worth $40K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 57 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $2.69K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3682 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Arena Pharmaceuticals Inc position peaked at $148K in Q4 2013.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.